The effects are presented as clinical events per 10,000 men, cost as Euros per man and cost-effectiveness as €/QALY. The four right most columns contrasts the clinical and costs as differences and cos
Introduction: Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death globally, characterized by airflow limitation and lung hyperinflation due to emphysema. Bronchoscopic lun
Additional file 3: Table S2. Estimated Average Health Care Utilization and Out-of-pocket Medical Spending Difference in Medical Aid Type II panel by difference-in-differences analysis. * Log Link with
